Ottawa, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The global human growth hormone injection market size is calculated at USD 4.82 billion in 2026 and is expected to reach around USD 8.54 billion by 2035, ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya® (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...

The FDA has approved three new pediatric indications for somapacitan-beco, a once-weekly, long-acting growth hormone injection, according to a press release issued by Novo Nordisk.Somapacitan-beco ...

WASHINGTON -- Children who are healthy but abnormally short will be able to have injections of growth hormone in hopes of gaining 1 to 3 more inches of height, the Food and Drug Administration said ...

Children born small for gestational age (SGA) exhibited impaired glucose-insulin metabolism, similar to children with obesity, which worsened under growth hormone therapy. In contrast, children with ...

Human growth hormone (hGH) is linked to muscle mass, weight loss, and increased athletic performance. You produce hGH naturally, but you can also get injections of recombinant growth hormone (rhGH).

There’s a way to take control of your HGH production naturally and through the use of both alternative and synthetic sources. When guys reach 30 years old, they enter a period known as “somatopause,” ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...